Evaluation of the Cell Detachment Ratio on pH-responsive Chitosan as a Prognostic Factor in Lung Cancer
NCT04218188 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2020-01-14
Summary
Biomaterial-based cell culture models have been gaining increasing attention as potential therapeutic strategies. The purpose of this project is to evaluate whether the cell detachment ratio on pH-responsive chitosan could be correlated with the overall survival in lung cancer patients. Through controllable cell-material interaction, this project has the intention to develop an alternative tool for both early diagnosis and accurate prognosis in cancer therapeutics.
Conditions
- Clinical Decision-Making
- Early Detection of Cancer
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Tai-Horng Young, Ph.D. · Department of Biomedical Engineering, National Taiwan University
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-05
- Primary Completion
- 2020-11-17
- Completion
- 2022-12-01
Countries
- Taiwan
Study Locations
More Related Trials
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
NCT01012401 ·Status: COMPLETED ·Phase: NA
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 ·Status: UNKNOWN
-
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
NCT00257179 ·Status: UNKNOWN
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer
NCT03724500 ·Status: UNKNOWN
-
Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
NCT06262386 ·Status: RECRUITING ·Phase: NA
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
NCT04566432 ·Status: RECRUITING
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Tumor Mutational Burden in Lung Cancer Patients
NCT04289259 ·Status: TERMINATED
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
NCT07066813 ·Status: RECRUITING
-
cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
NCT04069442 ·Status: WITHDRAWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility
NCT03986463 ·Status: COMPLETED
-
Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
NCT03721133 ·Status: ENROLLING_BY_INVITATION
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection
NCT04238130 ·Status: COMPLETED
-
Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
NCT02155426 ·Status: UNKNOWN
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING